Roper Technologies: EPS doubles on a 2026 reset while the stock still trades like it's flat

Stevie AI on Roper Technologies, Inc. (ROP-USA | ropertechnol)

10/27/2026

Summary

Roper Technologies is a 25-business software and industrial technology platform where roughly 85% of revenue now sits in Application Software and Network Software, businesses characterized by recurring subscription revenue, deep workflow embeddedness, and ~69% gross margins. The structural insight is that FY2025's reported EPS of $14.20 understates the earnings power of the underlying portfolio because of divestiture noise, acquisition accounting, and a transition year; FY2026 guidance of $22.35-22.40 implies EPS growth of nearly 58% year over year, a step-change that the market has not yet fully re-rated into the stock price. This is not purely organic acceleration — it reflects a cleaner earnings base, bolt-on M&A contribution, and margin expansion from software mix — but it resets the EPS trajectory meaningfully higher heading into 2027-2029. FY2024 revenue of $7.0B and net income of $1.5B gave way to FY2025 revenue of $7.9B (up 12.9%) while net income held flat at $1.5B and EPS actually declined slightly to $14.20 from $14.35, reflecting share count and mix effects during a transition year that included the Indicor Flow Controls divestiture process. The FY2026 guide of $22.35-22.40 DEPS, raised and narrowed from already-elevated prior guidance, signals management confidence in the current run-rate, with total revenue growth guided north of 8% (6% organic) and Q4 segment commentary showing broad-based mid-single-digit-plus organic growth across Application Software, Network Software, and Tech & Engineered Products. We apply a 24x forward P/E to FY2027 EPS of $24.25, reflecting Roper's quality profile (69% gross margin, 40% EBITDA margin, 31.6% FCF conversion) balanced against a deceleration in growth versus high-flying pure-play software comps and ongoing debt-funded M&A that keeps leverage near 2.8-3.0x net debt/EBITDA. This yields a FY2027 price target of $582, with FY2026 anchored off that via a step-up methodology and FY2028/FY2029 extending the multiple to EPS of $26.43 and $28.81 respectively, implying meaningful upside from the current $441.65 price across the forecast horizon.

Thesis

1. **Recurring software revenue underpins a resilient earnings base.** With Application Software (~50% of revenue) and Network Software (~35%) now comprising 85% of the business, Roper has structurally shifted away from cyclical industrial hardware toward subscription and workflow-embedded software. This mix shift is the primary driver of gross margin expansion toward 69% and EBITDA margins near 40%, and it provides a buffer against the 'weak capex, decelerating labor market' headwinds management flagged for the smaller Tech & Engineered Products segment. The durability of this recurring base — evidenced by mid-single-digit-plus organic growth guided across all three segments in Q4 — is the foundation for why FY2026 EPS guidance jumped so sharply versus FY2025 actuals. 2. **Niche market dominance limits competitive erosion.** Roper's 25 operating businesses — Deltek in government contractor ERP, DAT in freight logistics, Strata in hospital cost accounting — occupy fragmented, narrow verticals with limited direct public comparables. Decades of embedded customer relationships and proprietary data assets (e.g., Strata's GL mapping across thousands of provider implementations) create switching costs that are difficult to dislodge, even as larger horizontal software vendors attempt to encroach. This is a blue-ocean strategy by design: Roper scores 6.5/10 on Value Innovation precisely because it avoids red-ocean competition in favor of uncontested, mission-critical niches. 3. **AI agent monetization is a real, underappreciated optionality, not yet priced in.** Management has launched AI agents across 18+ businesses, with CentralReach reaching 75% of bookings and Aderant at 25% — concrete, quantifiable early proof points rather than vague AI-washing. While the commercialization phase is still nascent (management is explicitly in a 'tracking bookings/adoption/consumption' posture for 2027), this represents a market-expansion lever that converts non-consumption (manual back-office work) into incremental wallet share. None of our FY2027-2029 forecasts assume material AI monetization upside beyond what's embedded in organic growth assumptions, meaning there is asymmetric optionality not reflected in current estimates. 4. **Bolt-on M&A discipline, funded by FCF and divestiture proceeds, sustains the growth algorithm.** Roper's capital allocation model — debt-funded bolt-on acquisitions layered onto organic growth — has driven net debt from an implied base up to $11.8B by FY2029, keeping leverage near 2.8-3.0x EBITDA. The ~$600M pretax Indicor Flow Controls divestiture closing in Q4 2026 provides a clean capital source for either deleveraging or redeployment into higher-growth software bolt-ons, giving management optionality without needing to stretch the balance sheet further. 5. **The market is anchored to a stale, understated EPS base.** FY2025's EPS of $14.20 (down slightly from FY2024's $14.35 despite 12.9% revenue growth) reflects transition-year noise — divestiture-related drag, acquisition accounting, and share count effects — that masks the underlying earnings power of the portfolio. The FY2026 guide of $22.35-22.40 is not an aggressive stretch target but a raised and narrowed range reflecting actual YTD strength, meaning the step-change in EPS is highly visible and near-certain, yet the stock's current valuation at $441.65 does not yet reflect a market that has absorbed this EPS reset. 6. **Clear, near-term catalysts should force re-rating.** Q4 2026 earnings (expected early 2027) will confirm whether Q3 organic growth and margin trends hold, and will likely bring initial FY2027 guidance, which management has already characterized as 'generally constructive' with encouraging recurring-revenue exit run rates. The completion of the Indicor divestiture in the same quarter crystallizes ~$600M of capital optionality. Both catalysts converge within a single quarter, creating a natural inflection point for consensus estimates and investor attention to catch up to the EPS reset already embedded in guidance.

Risks

1. **AI monetization fails to scale beyond early adopters.** While CentralReach and Aderant show promising early bookings penetration (75% and 25% respectively), broader adoption across the remaining 16+ businesses with launched agents requires overcoming customer budget cycles, AI governance overlays (particularly acute in healthcare-facing businesses like Strata and CentralReach), and potentially elongated enterprise sales processes. If monetization stalls at the pilot stage, the market-expansion optionality central to the long-term bull case simply does not materialize, and growth reverts to a more pedestrian organic software algorithm. 2. **Leverage remains structurally elevated with limited margin for error.** Net debt is forecast to rise from an implied ~$8.6B base to $11.8B by FY2029, with leverage sustained near 2.8-3.0x net debt/EBITDA and periodic step-ups following large deals. A rate environment that stays higher for longer, or a large acquisition that pushes leverage meaningfully above this range, would pressure interest expense (already cited as a margin headwind) and could constrain the bolt-on M&A pace that is central to the growth algorithm. 3. **2027 segment-level uncertainty is explicitly flagged by management.** Management's own commentary described Deltek as 'wait-and-see,' Neptune as having a 'wider range of outcomes,' and NDI as needing to 'normalize from exceptional 2026 growth.' These are not minor line items — Deltek and NDI have been meaningful growth contributors, and if 2027 normalization is sharper than expected, consensus EPS estimates for FY2027 ($24.25 in our model) could see downward revisions even if the AI and core software narrative remains intact. 4. **Tech & Engineered Products exposure to industrial capex cycles.** Although now only ~15% of revenue, this segment remains exposed to 'weak capex, decelerating labor market' conditions explicitly cited in the forecast narrative. A sharper industrial slowdown than currently modeled would be a modest drag on consolidated organic growth and could disproportionately affect investor sentiment given Roper's Industrials sector classification, even though software now dominates the earnings mix. 5. **Valuation multiple compression risk if growth decelerates faster than guided.** Post-2026, growth is expected to normalize toward 7-7.5% as NDI/DAT lap tough comparisons and Subsplash becomes fully organic. Our 24x forward P/E assumes Roper sustains a premium multiple consistent with its margin profile; if growth decelerates below this normalized range without offsetting AI monetization upside, the market could compress the multiple toward more typical diversified industrial conglomerate levels (18-20x), eroding price target upside even if EPS estimates are met. 6. **Integration risk from a continuous, acquisitive capital allocation model.** Roper's decentralized bolt-on strategy requires consistent successful integration across dozens of businesses simultaneously. Any high-profile integration misstep, cultural mismatch, or overpayment for a larger deal (funded by Indicor proceeds or incremental debt) could both impair near-term FCF conversion (currently 31.6% of revenue) and raise questions about capital discipline that has historically been a key pillar of the bull case.

📈 Price Targets